欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Tyrosine Kinase-EGFR-JIN-A02
JIN-A02

Chemical Structure : JIN-A02

CAS No.:

JIN-A02

货号: PC-26083Not For Human Use, Lab Use Only.

JIN-A02 is a potent, mutant-selective, orally available fourth-generation EGFR tyrosine kinase inhibitor (EGFR-TKI), overcomes C797S-mediated resistance.

规格 价格 库存 数量

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

JIN-A02 is a potent, mutant-selective, orally available fourth-generation EGFR tyrosine kinase inhibitor (EGFR-TKI), overcomes C797S-mediated resistance.
JIN-A02 exhibits potent antiproliferative activity against a panel of Ba/F3 cell lines harboring clinically relevant EGFR mutations with IC90 of 117 nM (EGFR_E19del/C797S), 231 nM (EGFR_L858R/C797S), 192 nM (EGFR_E19del/T790M/C797S), and 359 nM (EGFR_L858R/T790M/C797S).
JIN-A02 demonstrates potent antiproliferative activity in preclinical NSCLC models harboring EGFR_C797S and T790M mutations, with superior inhibition of EGFR signaling compared to osimertinib.
JIN-A02 elicited substantial tumor regression, indicating robust in vivo efficacy in both subcutaneous and orthotopic intracranial xenograft NSCLC models.

物理化学性质&存储条件

分子量
分子式
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

参考文献

1. Lee EJ, et al. Clin Cancer Res. 2026 Feb 6. doi: 10.1158/1078-0432.CCR-25-3720.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: